Clinical Trials Browser

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT03508765 2024-03-08

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Phase NA Completed

18 enrolled

Plasma cell

Multiple Myeloma

NCT04872023 2023-02-03

IMMUNO-MYELO

Phase NA Completed

5 enrolled

Plasma cell

Multiple Myeloma

NCT02627261 2022-09-06

MMRD

Completed

48 enrolled

Plasma cell

Multiple Myeloma, Neoplasm, Residual

NCT04150692 2022-01-24

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Phase 2 Withdrawn

Plasma cell

Multiple Myeloma

NCT03956615 2021-12-01

MUM

Phase NA Completed

10 enrolled 6 charts

Plasma cell

Multiple Myeloma

NCT03665155 2021-07-30

First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody

Phase 1/2 Completed

11 enrolled 11 charts

Plasma cell

Multiple Myeloma

NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Phase NA Completed

30 enrolled 8 charts

LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

NCT01472627 2018-01-11